TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$14.750-0.110 (-0.740%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$14.860

Haut

$15.001

Bas

$14.420

Volume

0.49M

Fondamentaux de l'Entreprise

Capitalisation Boursière

742.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.42M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $7.9Actuel $14.750Haut $15.335

Actualités Connexes

PR Newswire

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous...

Voir plus
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
PR Newswire

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on...

Voir plus
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire...

Voir plus
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.